Mast Cell Interleukin-2 Production Contributes to Suppression of Chronic Allergic Dermatitis

Immunity

Volumn 35, Issue 4, 2011, Pages 562-571

  Hershko, Alon Y ^a   Suzuki, Ryo ^a   Charles, Nicolas ^a   Alvarez Errico, Damiana ^a   Sargent, Jennifer L ^a   Laurence, Arian ^a   Rivera, Juan ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; OXAZOLONE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL COMMUNICATION; CELL EXPANSION; CELLULAR IMMUNITY; CHRONIC ALLERGIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEFENSE MECHANISM; DISEASE COURSE; DISEASE EXACERBATION; HISTOPATHOLOGY; IMMUNOMODULATION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN ALLERGY; SKIN INFLAMMATION; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; CHRONIC DISEASE; DERMATITIS, ATOPIC; IMMUNOGLOBULIN E; INTERLEUKIN-2; MAST CELLS; MICE; MICE, KNOCKOUT; OXAZOLONE; SPLEEN;

EID: 80755128535     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.07.013     Document Type: Article

References (49)

1. Bachelet I., Levi-Schaffer F. Mast cells as effector cells: a co-stimulating question. Trends Immunol. 2007, 28:360-365.
2. Bieber T. Atopic dermatitis. N. Engl. J. Med. 2008, 358:1483-1494.
3. Biedermann T., Kneilling M., Mailhammer R., Maier K., Sander C.A., Kollias G., Kunkel S.L., Hültner L., Röcken M. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 2000, 192:1441-1452.
4. Boudousquié C., Pellaton C., Barbier N., Spertini F. CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma. Clin. Exp. Allergy 2009, 39:1415-1426.
5. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
6. Bryce P.J., Miller M.L., Miyajima I., Tsai M., Galli S.J., Oettgen H.C. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE on mast cells. Novartis Found. Symp. 2005, 271:15-24. discussion 24-38, 95-99.
7. Charles N., Watford W.T., Ramos H.L., Hellman L., Oettgen H.C., Gomez G., Ryan J.J., O'Shea J.J., Rivera J. Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity 2009, 30:533-543.
8. Curotto de Lafaille M.A., Kutchukhidze N., Shen S., Ding Y., Yee H., Lafaille J.J. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008, 29:114-126.
9. Depinay N., Hacini F., Beghdadi W., Peronet R., Mécheri S. Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J. Immunol. 2006, 176:4141-4146.
10. Dudeck A., Dudeck J., Scholten J., Petzold A., Surianarayanan S., Köhler A., Peschke K., Vöhringer D., Waskow C., Krieg T., et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011, 34:973-984.
11. Evans D.P., Hossack M., Thomson D.S. Inhibition of contact sensitivity in the mouse by topical application of corticosteroids. Br. J. Pharmacol. 1971, 43:403-408.
12. Ezeamuzie C.I., Al-Attiyah R., Shihab P.K., Al-Radwan R. Low-affinity IgE receptor (FcepsilonRII)-mediated activation of human monocytes by both monomeric IgE and IgE/anti-IgE immune complex. Int. Immunopharmacol. 2009, 9:1110-1114.
13. Friend D.S., Gurish M.F., Austen K.F., Hunt J., Stevens R.L. Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection. J. Immunol. 2000, 165:344-352.
14. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008, 8:478-486.
15. Gonzalez-Espinosa C., Odom S., Olivera A., Hobson J.P., Martinez M.E., Oliveira-Dos-Santos A., Barra L., Spiegel S., Penninger J.M., Rivera J. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 2003, 197:1453-1465.
16. Gri G., Piconese S., Frossi B., Manfroi V., Merluzzi S., Tripodo C., Viola A., Odom S., Rivera J., Colombo M.P., Pucillo C.E. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008, 29:771-781.
17. Grimbaldeston M.A., Chen C.C., Piliponsky A.M., Tsai M., Tam S.Y., Galli S.J. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 2005, 167:835-848.
18. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 2007, 8:1095-1104.
19. Hart P.H., Grimbaldeston M.A., Swift G.J., Jaksic A., Noonan F.P., Finlay-Jones J.J. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J. Exp. Med. 1998, 187:2045-2053.
20. Hershko A.Y., Rivera J. Mast cell and T cell communication; amplification and control of adaptive immunity. Immunol. Lett. 2010, 128:98-104.
21. Jin H., He R., Oyoshi M., Geha R.S. Animal models of atopic dermatitis. J. Invest. Dermatol. 2009, 129:31-40.
22. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat. Immunol. 2008, 9:1215-1223.
23. Kamimura D., Sawa Y., Sato M., Agung E., Hirano T., Murakami M. IL-2 in vivo activities and antitumor efficacy enhanced by an anti IL-2 mAb. J. Immunol. 2006, 177:306-314.
24. Kohm A.P., McMahon J.S., Podojil J.R., Begolka W.S., DeGutes M., Kasprowicz D.J., Ziegler S.F., Miller S.D. Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J. Immunol. 2006, 176:3301-3305.
25. Kurashima Y., Kunisawa J., Higuchi M., Gohda M., Ishikawa I., Takayama N., Shimizu M., Kiyono H. Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy. J. Immunol. 2007, 179:1577-1585.
26. Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New insights into atopic dermatitis. J. Clin. Invest. 2004, 113:651-657.
27. Leung A.K., Hon K.L., Robson W.L. Atopic dermatitis. Adv. Pediatr. 2007, 54:241-273.
28. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006, 442:997-1002.
29. Malek T.R., Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 2004, 4:665-674.
30. Man M.Q., Hatano Y., Lee S.H., Man M., Chang S., Feingold K.R., Leung D.Y., Holleran W., Uchida Y., Elias P.M. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J. Invest. Dermatol. 2008, 128:79-86.
31. Matsui K., Nishikawa A. Percutaneous application of peptidoglycan from Staphylococcus aureus induces mast cell development in mouse spleen. Int. Arch. Allergy Immunol. 2006, 139:271-278.
32. Matsumoto K., Mizukoshi K., Oyobikawa M., Ohshima H., Tagami H. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments. Skin Res. Technol. 2004, 10:122-129.
33. Mekori Y.A., Metcalfe D.D. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 1999, 104:517-523.
34. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 2006, 176:2238-2248.
35. Norman M.U., Hwang J., Hulliger S., Bonder C.S., Yamanouchi J., Santamaria P., Kubes P. Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. Am. J. Pathol. 2008, 172:1638-1649.
36. Phanuphak P., Moorhead J.W., Claman H.N. Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. J. Immunol. 1974, 112:115-123.
37. Piconese S., Gri G., Tripodo C., Musio S., Gorzanelli A., Frossi B., Pedotti R., Pucillo C.E., Colombo M.P. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009, 114:2639-2648.
38. Pritchard H., Micklem H.S. Immune responses in congenitally thymus-less mice. I. Absence of response to oxazolone. Clin. Exp. Immunol. 1972, 10:151-161.
39. Sadlack B., Löhler J., Schorle H., Klebb G., Haber H., Sickel E., Noelle R.J., Horak I. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 1995, 25:3053-3059.
40. Schultz Larsen F., Diepgen T., Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J. Am. Acad. Dermatol. 1996, 34:760-764.
41. Secor V.H., Secor W.E., Gutekunst C.A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 2000, 191:813-822.
42. Stelekati E., Bahri R., D'Orlando O., Orinska Z., Mittrücker H.W., Langenhaun R., Glatzel M., Bollinger A., Paus R., Bulfone-Paus S. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009, 31:665-676.
43. Sugiura S., Fujimiya M., Ebise H., Miyahira Y., Kato I., Sugiura Y., Kimura T., Uehara M., Sato H., Sugiura H. Immunosuppressive effect of prolactin-induced protein: a new insight into its local and systemic role in chronic allergic contact dermatitis. Br. J. Dermatol. 2010, 162:1286-1293.
44. Suto H., Nakae S., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 2006, 176:4102-4112.
45. Tanzola M.B., Robbie-Ryan M., Gutekunst C.A., Brown M.A. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 2003, 171:4385-4391.
46. Wang H.W., Tedla N., Lloyd A.R., Wakefield D., McNeil P.H. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 1998, 102:1617-1626.
47. Wilson M.S., Pesce J.T., Ramalingam T.R., Thompson R.W., Cheever A., Wynn T.A. Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. J. Immunol. 2008, 181:6942-6954.
48. Wolters P.J., Mallen-St Clair J., Lewis C.C., Villalta S.A., Baluk P., Erle D.J., Caughey G.H. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin. Exp. Allergy 2005, 35:82-88.
49. Zheng L., Sharma R., Gaskin F., Fu S.M., Ju S.T. A novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: both IL-2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms. J. Immunol. 2007, 179:8035-8041.